ArticleFrontiers in immunology2022
An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response.
Li Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it